NCT05566249 A Study to Validate the Safety and Feasibility of ArtiSential in Colorectal Cancer Surgery Using Prospectively Constructed Multi-center Registry
| NCT ID | NCT05566249 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Samsung Medical Center |
| Condition | Rectal Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2022-10-01 |
| Primary Completion | 2024-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2022-10-01 with a primary completion date of 2024-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is to validate the safety and feasibility of ArtiSential (Articulating laparoscopic instrument) colorectal surgery and compare it with robotic surgery for patients with rectal cancer and rectosigmoid junction cancer.
Eligibility Criteria
Inclusion Criteria: * Age : 18 \~ 80 year old male or female * Biopsy-proven adenocarcinoma * Rectal cancer or Rectosigmoid junction cancer * Primary cancer * Non-metastatic cancer * Planned (or elective) curative resection * Low anterior resection with double-stapled technique Exclusion Criteria: * Preoperative systemic chemotherapy * Distant metastasis at initial diagnosis * Palliative surgery * Emergent surgery * Lynch syndrome or FAP-associated cancer
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05566249 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Rectal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05566249 currently recruiting?
Yes, NCT05566249 is actively recruiting participants. Contact the research team at jungwook.huh@gmail.com for enrollment information.
Where is the NCT05566249 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT05566249 clinical trial?
NCT05566249 is sponsored by Samsung Medical Center. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.